tremelimumab

Pharma

Another AstraZeneca Emerald glimmers in liver cancer

Another green light appears increasingly within reach for AZ’s Emerald program, as Imfinzi and Imjudo showed a PFS benefit in locoregional liver cancer.

Angus Liu Apr 2, 2026 10:12am

China indicts AstraZeneca and former exec Leon Wang

Feb 11, 2026 11:13am

AstraZeneca logs China sales decline in Q4 amid probes

Feb 6, 2025 10:31am

ASCO: AZ's latest Tagrisso data receive standing ovation

Jun 3, 2024 7:37am

AstraZeneca’s Imfinzi tackles another type of lung cancer

Apr 5, 2024 10:22am

BMS, AZ settle cancer immunotherapy patent suits for $510M

Aug 1, 2023 10:09am